3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
11
Breast Neoplasms
11
Obesity
8
Motor Activity
7
Malnutrition
6
Lung Neoplasms
6
Prostatic Neoplasms
5
Overweight
5
Colorectal Neoplasms
5
Weight Loss
4
Hypertension
4
Stroke
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Heart Failure
3
Diabetes Mellitus
3
Cardiovascular Diseases
3
Sarcopenia
2
Polycystic Ovary Syndrome
2
Osteoporosis
2
Kidney Diseases
2
Inflammation
2
Heart Diseases
2
Gastrointestinal Neoplasms
2
Frailty
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Cachexia
2
Arthritis
2
Interventions
relacorilant
5
Resistance Training
3
Pioglitazone
2
Nutritional Status
2
Metformin
2
saxagliptin
1
pembrolizumab
1
mazdutide
1
dapagliflozin
1
Sitagliptin Phosphate
1
Resistant Starch
1
Plant Proteins
1
Nutrition Assessment
1
Methods
1
Insulin Lispro
1
Insulin Glargine
1
Exercise Movement Techniques
1
Exercise
1
Ethanol
1
Endodontics
1
Educational Status
1
Early Intervention, Educational
1
Diet
1
Continuous Glucose Monitoring
1
Circuit-Based Exercise
1
Cholecalciferol
1
Blood Specimen Collection
1
Ascorbic Acid
1
ASP3662
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diabetes Mellitus, Type 2
×
Nutrition Assessment
×
Clear all
NCT07126587
2025-10-30
HLA
University of North Carolina, Chapel Hill
Phase NA
Recruiting
120 enrolled